Similar Articles
251 Assessing recent recurrence after hepatectomy for hepatitis B-related hepatocellular carcinoma by a predictive model based on sarcopenia
252 Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma
253 Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status
254 Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
255 Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma
256 Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis
257 MicroRNAs in hepatocellular carcinoma treatment: Charting the path forward
258 Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040?
259 Chinese herbal medicine decreases incidence of hepatocellular carcinoma in diabetes mellitus patients with regular insulin management
260 Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA